Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00060541 · ClinicalTrials.gov registry record
Evaluation and Treatment of Neurosurgical Disorders
A clinical trial of Neurologic Disorders, sponsored by National Institute of Neurological Disorders and Stroke (NINDS).
- Recruiting
- Registry status
- 5,000
- Enrollment target
- 1
- Study location
NCT00060541: Recruiting study of Neurologic Disorders, sponsored by National Institute of Neurological Disorders and Stroke (NINDS).
NCT00060541 is a study of Neurologic Disorders that is actively recruiting participants, run by National Institute of Neurological Disorders and Stroke (NINDS). The registered enrollment target is 5,000 participants, above the 2,412-participant average among 5 other Neurologic Disorders trials with a reported enrollment target (107% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00060541, a study of Neurologic Disorders, is actively recruiting participants, sponsored by National Institute of Neurological Disorders and Stroke (NINDS).
- RECRUITING
- Registry status
- 5,000 participants
- Enrollment target
- 1
- Study location
Study Summary
Objective: This protocol is designed to allow evaluation of participants neurosurgical disorders that receive care within the Surgical Neurology Branch. The participants will receive standard-of-clinical-care evaluation and treatment. The clinical data and samples generated during standard of care treatment will be collected as a part of this study. Study Population: Participants 4 years of age and older with neurosurgical-related conditions seeking care from, or referred to the Surgical Neurology Branch for evaluation are eligible for this protocol. Study Design: This is an observational study. Participants will receive standard-of- clinical-care evaluation and treatment for their neurosurgical condition. Clinical evaluation may include laboratory and radiological studies designed to aid in diagnosis or differential diagnosis of the participant s condition or to facilitate treatment. The evaluations may take place in the outpatient clinic areas or in the inpatient units. Some participants will receive standard-of-care medical or surgical treatment for their disorder. Clinical data, tissue samples or body fluids obtained during standard of care treatment, may be used for research. Additional genetic testing may be performed on subjects and their blood relatives if a genetic mechanism underlying the neurological disorder is suspected. Patients in this study may choose to consent to skin biopsies for research purposes, in which case they will sign an additional consent document for thesethis research procedure. Outcome Measures: No additional research outcome measures will be tracked in this study, as this study is collecting data for potential future use. All outcomes will be those of standard clinical evaluation and treatment. A clinical and research database will be kept of patient s diagnosis, progression, and treatment. Clinical database information may be reported or be used in other studies.
Primary Outcome
standard clinical evaluation and treatment
Conditions Studied
Interventions
- PROCEDURE Laboratory tests
- PROCEDURE Radiological exams
Study Locations (1)
Maryland
- National Institutes of Health Clinical Center - Bethesda
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5,000 participants |
| Start Date | 2003-06-04 |
What NCT00060541 shows while recruiting
NCT00060541 is an observational study that tracks outcomes without assigning an intervention. Its 5,000 participants enrollment target places it among the larger protocols in the corpus, above the 2,412-participant average among 5 other Neurologic Disorders trials with a reported enrollment target (107% higher).
The record links to 1 condition, with Neurologic Disorders appearing as the primary indexed condition, and to 2 interventions - of which Laboratory tests is the first listed.
NCT00060541 reports a single indexed study location in Maryland.
Frequently Asked Questions
What is clinical trial NCT00060541 about?
NCT00060541 is a clinical study titled "Evaluation and Treatment of Neurosurgical Disorders". Objective: This protocol is designed to allow evaluation of participants neurosurgical disorders that receive care within the Surgical Neurology Branch. The participants will receive standard-of-clinical-care evaluation and treatment. The clinical data and samples generated during standard of care t...
What is the current status of trial NCT00060541?
This trial is currently recruiting. The enrollment target is 5,000 participants. The study started on 2003-06-04.
What conditions does trial NCT00060541 study?
This clinical trial studies the following conditions: Neurologic Disorders.
What interventions are being tested in trial NCT00060541?
The interventions under investigation include: Laboratory tests (PROCEDURE), Radiological exams (PROCEDURE).
Who is sponsoring clinical trial NCT00060541?
This trial is sponsored by National Institute of Neurological Disorders and Stroke (NINDS), which has 567 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00060541 being conducted?
This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Neurologic Disorders
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Neurologic Stem Cell Treatment Study
RECRUITING · NA
-
Reliability and Validity of the PReFS
RECRUITING
-
Mesenchymal Stem Cells for the Treatment of Various Chronic and Acute Conditions
RECRUITING · Phase 1
-
The Neurodevelopmental and Behavioral Phenotyping Screening Protocol
RECRUITING
-
Epidemiology of Sleep-Disordered Breathing in Adults
ACTIVE NOT RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00575081 · 5,000 participants
Physiological Brain Atlas Development
- NCT00736749 · 5,000 participants
Long-Term Follow-Up of Patients Who Have Participated in Children's Oncology Group Studies
- NCT00900198 · 5,000 participants
Collection of Tissue Samples for Cancer Research
- NCT00991094 · 5,000 participants
Data Collection for the Assessment of Acute and Late Normal Tissue in Patients Treated With Proton Therapy
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI